GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer breakthrough? new PET-Guided radiation aims to outsmart glioblastoma
Disease control Recruiting nowThis study tests a new radiation approach for people with glioblastoma, an aggressive brain cancer, who are too frail for standard surgery. The method uses a special PET scan (FDOPA) to find the most dangerous parts of the tumor and delivers a higher radiation dose only to those …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New radiation combo shows promise in tough brain cancer battle
Disease control Recruiting nowThis study tests a new drug, TLX101-Tx, which delivers radiation directly to glioblastoma cells, combined with standard chemotherapy (lomustine) in 50 adults whose brain cancer has returned after initial treatment. The goal is to see if the combination helps control the tumor bet…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Sound waves plus drug may slow aggressive brain tumor return
Disease control Recruiting nowThis study tests whether adding focused ultrasound (NaviFUS) to the standard drug Avastin can help people with recurrent glioblastoma, a serious brain cancer. About 32 adults whose tumor has come back after prior treatment will be randomly assigned to get Avastin alone or Avastin…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Gene-Protected stem cells may allow higher chemo doses against deadly brain tumors
Disease control Recruiting nowThis study tests a new approach for people with a severe brain cancer called glioblastoma. Researchers take a patient's own blood stem cells, add a protective gene, and return them so the bone marrow can withstand higher doses of chemotherapy. The goal is to safely give stronger …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Could a new drug combo extend life in aggressive brain cancer?
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard treatment (radiation and temozolomide) helps people with newly diagnosed glioblastoma live longer. About 190 adults will be randomly assigned to receive either the standard treatment alone or standard treatment plus…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC